High school teacher Marcus Mitchell, 35, is the first adult at Duke University Hospital to undergo this gene therapy aimed at curing sickle cell disease.

Chantez Sanford Jr., 24, of Southfield, says his life has been transformed after undergoing Lyfgenia gene therapy at Children's Hospital of Michigan.

Avascular necrosis is the breakdown and death of bone tissue due to insufficient blood supply. It’s a common complication of sickle cell disease, but early diagnosis and treatment can help slow ...

Company has already submitted proposed confirmatory trial for FDA review, as required under accelerated approval pathway Company plans to submit ...

Individuals with sickle cell disease – a chronic illness where misshapen, sticky blood cells clump together, reducing oxygen delivery to organs – are at a higher risk for stroke and resulting ...

Sickle cell disease (SCD) is a group of genetic blood disorders. A person inherits SCD from their parents when they inherit two copies of the sickle cell gene, one from each parent. This hereditary ...

Objectives To estimate the prevalence of sickle cell trait, sickle cell disease, beta-thalassaemia minor and ...

How is it that you’re alive? It’s a question that we rarely ask ourselves—but it’s one that has a definite answer. We all know our heart pumps life-giving oxygen throughout our bodies. How does that ...

Opinion: Thousands of Marylanders are living with sickle cell disease, but our health care system has not kept pace with our ...